Renaissance Technologies’s Coya Therapeutics COYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
192,986
+89,022
+86% +$412K ﹤0.01% 2255
2026
Q1
$410K Buy
103,964
+37,064
+55% +$173K ﹤0.01% 2681
2025
Q4
$388K Buy
66,900
+32,100
+92% +$195K ﹤0.01% 2675
2025
Q3
$198K Buy
34,800
+20,800
+149% +$127K ﹤0.01% 3135
2025
Q2
$80.5K Buy
14,000
+1,800
+15% +$10.4K ﹤0.01% 3334
2025
Q1
$78.9K Buy
+12,200
New +$77.2K ﹤0.01% 3227
2024
Q4
Sell
-17,200
Closed -$111K 3622
2024
Q3
$111K Buy
17,200
+500
+3% +$3.15K ﹤0.01% 3243
2024
Q2
$101K Buy
+16,700
New +$134K ﹤0.01% 3182

Other funds holding COYA

Renaissance Technologies's COYA Position: Q2 2026 in Review

Renaissance Technologies increased its Coya Therapeutics (COYA) stake by 86% in Q2 2026, buying an estimated $412K and bringing the position to 192,986 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

Renaissance Technologies first reported a position in COYA in Q2 2024 and has held it in 8 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Renaissance Technologies held 192,986 shares of Coya Therapeutics worth $1.13M as of Q2 2026.
  • Renaissance Technologies bought 89,022 Coya Therapeutics shares in Q2 2026, an estimated $412K.
  • Coya Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2255 holding.
  • Renaissance Technologies first reported a position in Coya Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.